April 8 (Reuters) - Lab equipment maker Waters said on Wednesday the U.S. Food and Drug Administration has cleared its ...

Waters Corporation (WAT) stock gains as the FDA clears the company's Onclarity HPV self-collection kit for use with BD’s (BDX ...

Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV ...

The US FDA's approval of Waters' at-home cervical cancer screening kit marks a significant step in enhancing early detection and reducing fatalities. This move positively impacted Waters' stocks, ...

Waters Corporation WAT shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV ...

Add Yahoo as a preferred source to see more of our stories on Google. Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical cancer screening guidelines ...

According to the World Health Organization (WHO), in 2022 cervical cancer was the fourth most common cancer among women worldwide, with about 660,000 new cases. Studies project that cervical cancer ...

The American Cancer Society is endorsing the use of self-swab kits to test for HPV, because they may reduce barriers to cervical cancer screening. The amended guidelines will "help improve compliance ...

The findings of a new study add to growing evidence that cotesting may offer limited clinical value despite its common use in ...

Communication for Development and Advocacy Consult (CDA Consult) has urged women not to avoid cervical cancer screening based ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical ...

FDA-approved BD Onclarity HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection ...